Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019 Year: 2020
Functional status in high and low risk patient with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in COPD Year: 2013
Systemic effects in patients with chronic obstructive pulmonary disease: a role of disease duration and disease severity Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009
Effects of lung development on pulmonary function tests: from early life to chronic respiratory disease Source: Virtual Congress 2020 – Chronic respiratory diseases and their origins in early life: how physiology meets clinical medicine Year: 2020
Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008
The influence of SARS-CoV-2 co-infection and active tuberculosis on the severity of the disease course and mortality. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021
Effect of disease duration on pulmonary function in asthma Source: Eur Respir J 2001; 18: Suppl. 33, 34s Year: 2001
Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015
Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007
Exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2007; 29: 1224-1238 Year: 2007
Impact of pulmonary tuberculosis infection on chronic obstructive pulmonary disease Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011
Assessing cardiocirculatory compensation capacity in COPD: impact of disease severity. Source: Virtual Congress 2020 – Respiratory diseases, hypoxia and cardiovascular function Year: 2020
The impact of a network based approach on lung function and symptom duration at diagnosis in idiopathic pulmonary fibrosis Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018
Different chronic obstructive pulmonary disease phenotypes, systemic inflammation and the risk of falls Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016
Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015
Chronic obstructive pulmonary disease phenotypes, nutritional status and the risk of falls Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases Year: 2016
Impact of chronic bronchial infection on the lungs and beyond Source: Eur Respir Monogr 2013; 60: 46-57 Year: 2013
Does the severity of chronic obstructive pulmonary disease reflect on the outcomes of pulmonary rehabilitation? Source: Annual Congress 2007 - Assessment and outcomes in patients with chronic airway obstruction Year: 2007
Lung function and body weight influence the outcome of pulmonary rehabilitation in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 356s Year: 2001
Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression? Source: Eur Respir J , 49 (2) 1602524; DOI: 10.1183/13993003.02524-2016 Year: 2017